Abstract
Neonatal gastrointestinal colonization of newborn rats with Escherichia coli 075:K100:H5, cross-reactive with the capsular polysaccharide of Haemophilus influenzae type b, was harmless but failed to stimulated detectable ( greater than 200 ng/ml) serum anticapsular antibodies. Neonatally colonized rats, when challenged at age 13 weeks by intraperitoneal inoculation of H. influenzae b, showed no difference in the frequency, magnitude, or duration of bacteremia or in the postinfection anticapsular antibody response when compared with saline-fed controls. However, neonatally colonized rats challenged at age 4 weeks had a significantly decreased incidence of sustained bacteremia and/or endophthalmitis when compared with controls. This decreased frequency of disease correlated with a significant increase in postinfection serum anticapsular antibodies. Neonatal gastrointestinal colonization with cross-reacting E. coli appears to "prime" the young host to respond to infection with H. influenzae b with an anticapsular antibody response that protects against sustained H. influenzae b bacteremia and its complications.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.